aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company has developed a platform for controlled colonization of the gut with engineered bacteria, enabling first-in-class living therapeutics known as Genetically Engineered Microbial Medicines (GEMMs). Novome's lead preclinical program targets hyperoxaluria, a condition characterized by excessive oxalate levels.
Key achievements include the development of the first-ever platform for controlled gut colonization with engineered bacteria. Novome's innovative approach has the potential to revolutionize chronic disease treatment by leveraging the human microbiome. The company's impact is significant in the field of living therapeutics, positioning it as a pioneer in gut microbiota engineering.
Operating Status
Active
Ownership Type(s)
Venture Capital, Equity
Main Product(s)
Therapeutics
Technology
AI, Biotech
Tags
Platform
Model Types
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Novome Biotechnologies founded?
Novome Biotechnologies was founded in 2016.
Where is Novome Biotechnologies’s headquarters located?
Novome Biotechnologies’s headquarters is located in South San Francisco, CA, US.
When was Novome Biotechnologies’s last funding round?
Novome Biotechnologies’s most recent funding round was for $43.5M (USD) in September 2022.
How many employees does Novome Biotechnologies have?
Novome Biotechnologies has 30 employees as of Feb 5, 2024.
How much has Novome Biotechnologies raised to-date?
As of July 05, 2023, Novome Biotechnologies has raised a total of $83.1M (USD) since Sep 13, 2022.
Add Comparison
Total Raised to Date
$83.1M
USD
Last Update Sep 13, 2022
Last Deal Details
$43.5M
USD
Sep 13, 2022
Series B
Total Employees Over Time
30
As of Feb 2024
Novome Biotechnologies Address
201 Haskins Way
South San Francisco,
California
94080
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts